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Abstract
Aims/hypothesis Increasing the expression of the brown
adipose tissue-specific gene uncoupling protein-1 (Ucp1)i s
a potential target for treating obesity. We investigated the
role of DNA methylation and histone modification in Ucp1
expression in adipose cell lines and ex vivo murine adipose
tissues.
Methods Methylation state of the Ucp1 enhancer was
studied using bisulphite mapping in murine adipose cell
lines, and tissue taken from cold-stressed mice, coupled
with functional assays of the effects of methylation and
demethylation of the Ucp1 promoter on gene expression
and nuclear protein binding.
Results We show that demethylation of the Ucp1 promoter
by 5-aza-deoxycytidine increases Ucp1 expression while
methylation of Ucp1 promoter–reporter constructs
decreases expression. Brown adipose tissue-specific Ucp1
expression is associated with decreased CpG dinucleotide
methylation of the Ucp1 enhancer. The lowest CpG
dinucleotide methylation state was found in two cyclic
AMP response elements (CRE3, CRE2) in the Ucp1
promoter and methylation of the CpG in CRE2, but not
CRE3 decreased nuclear protein binding. Chromatin im-
munoprecipitation assays revealed the presence of the
silencing DiMethH3K9 modification on the Ucp1 enhancer
in white adipose tissue and the appearance of the active
TriMethH3K4 mark at the Ucp1 promoter in brown adipose
tissue in response to a cold environment.
Conclusions/interpretation The results demonstrate that
CpG dinucleotide methylation of the Ucp1 enhancer
exhibits tissue-specific patterns in murine tissue and cell
lines and suggest that adipose tissue-specific Ucp1 expres-
sion involves demethylation of CpG dinucleotides found in
regulatory CREs in the Ucp1 enhancer, as well as
modification of histone tails.
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Introduction
Obesity is a major risk factor for the development of
diabetes and cardiovascular disease. Treatments for obesity
have centred on decreasing appetite rather than increasing
energy expenditure because humans proved to be refractory
to β-adrenergic agonists aimed at inducing an increase in
brown adipose tissue (BAT) thermogenesis. This was
despite promising work in rodents that energy expenditure
can be increased by β-selective adrenergic stimulation of
the brown fat thermogenic gene, uncoupling protein 1
(Ucp1)[ 1]. Recently there has been renewed interest in the
role of BAT in humans since fluorodeoxyglucose positron
emission tomography has revealed the presence of BAT
depots in adult humans [2]. Furthermore, human white
adipocytes can acquire the molecular features of brown
adipocytes [3]. Therefore, increasing the numbers of brown
adipocytes in humans has been suggested to be a potential
target for treating obesity [4, 5].
We have demonstrated that suppressed adrenergic-
sensitive Ucp1 expression in the white adipocyte 3T3-L1
cell line is not the result of inhibition of adrenergic
signalling, and can be stimulated by enhancing transcrip-
tional activity from the cyclic AMP response elements
(CREs) in BAT genes [4, 5]. Our earlier studies on the
ontogenic development of BAT in sheep, suggested that this
species was similar to humans in that adrenergic-sensitive
Ucp1 expression was suppressed soon after birth [6].
Methylation of CpG dinucleotides in gene promoters is
thought to play a key role during the developmental control
of cell-specific gene expression in association with histone
tail modification to regulate chromatin structure and
function [7]. These data suggested to us that gene silencing
mechanisms involving DNA methylation of CREs and
chromatin remodelling may be important in regulating
Ucp1 expression.
BAT is characterised by large numbers of mitochondria,
increased fatty acid oxidation and a capacity for high
metabolic rate due to the action of Ucp1, which uncouples
oxidative phosphorylation [8]. Ucp1 expression is BAT-
specific and is regulated by a basal promoter ∼250 bp
upstream from the start of transcription, a silencer unit at
−1000 kb, and a highly conserved 221 bp enhancer element
located approximately −2.5 kb from the transcriptional start
site in the mouse and rat promoters and −3.9 kb in the
human promoter. A number of binding sites for nuclear
receptors and bZIP transcriptional factors are located in the
enhancer region and have been shown to play functional
roles in the stimulation of Ucp1 expression by β-adrenergic
and nuclear receptor agonists [9]. Sympathetic stimulation
increases Ucp1 expression via protein kinase A-activated
binding of cyclic AMP response element binding protein
(CREB) to four CREs in the Ucp1 enhancer and promoter
regions [10]. The enhancer region also appears to be
responsible for tissue-specific expression of Ucp1 [11]
through the interaction between PRDM16, peroxisome
proliferator activated receptor gamma coactivator 1alpha
(PGC-1α) and peroxisome proliferator activated receptor
gamma (PPARγ) acting at the peroxisome proliferator
activated receptor response element (PPARE) [12], brown
fat regulatory element and the nuclear factor erythroid
response element (NF-E2) sites [9].
Methylation of discrete CpGs can modulate the binding
of important transcription factors, thereby altering gene
expression, including regulating tissue specificity (e.g.
leptin and glucose transporter 4 [GLUT4]) [13–16].
Previous studies have demonstrated that the consensus
CRE motif which contains a CpG dinucleotide is a target
for DNA methylation and suppresses gene expression [17–
19]. Furthermore, the nuclear hormone corepressor,
RIP140, increases the assembly of histone methyltrans-
ferases on the Ucp1 promoter leading to the methylation of
specific CpGs, whereas increased active histone acetylation
and decreased repressive histone marks have been reported
in Rip140 (nuclear receptor-interacting protein 1, also
known as Nrip1)
−/− mouse embryonic fibroblasts [20].
Adrenergic stimulation and cold stress in rodents
increase energy expenditure by stimulating expression of
Ucp1 in the interscapular BAT depot during the recruitment
of BAT in this depot [21] and by the appearance of brown
adipocytes in white adipose tissue (WAT) [8, 22, 23]. The
mechanisms underlying the tissue-specific expression of
Ucp1 expression are currently unknown. Here we demon-
strate that CpG dinucleotide methylation differs between
tissues and together with histone modification is involved
in the regulation of Ucp1 gene expression.
Methods
Animal experiments Two groups of C57BL/6 mice (Harlan,
Loughborough, UK), each consisting of four females, were
housed individually in cages measuring 48×15×13 cm
with a 16 h light and 8 h dark cycle with access to bedding
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mouse chow diet. Mouse weight and feed consumption
were measured at 24 h intervals. One group was kept at 22
±2°C for 72 h (control warm-acclimatised group). A second
group was kept at 22±2°C for 48 h followed by 8±2°C for
24 h and comprised the cold-acclimatised group. All
experiments followed institutional guidelines at the Uni-
versity of Aberdeen and those set out for animal care by the
UK Home Office. Animals were killed by concussion
followed by cervical dislocation following Home Office
guidelines.
Cell culture Medium, sera, vitamins solution and antibiotics/
antimycotics were bought from GIBCO BRL (Paisley, UK).
3T3-L1 cells (ECACC, Salisbury, UK) and HIB-1B cells
(kindly provided by B. Spiegelman) were maintained in
DMEM with 10% FBS (Invitrogen, Carlsbad, CA, USA) in
5% CO2. For differentiation, HIB-1B cells were cultured to
confluence (day 0) and then exposed to the differentiation
cocktail (0.5 mmol/l 3-isobutyl-1-methylxanthine,
250 nmol/l dexamethasone, 170 nmol/l insulin, 10 nmol/l
T3). After 48 h, cells were maintained in medium containing
5% FBS, 170 nmol/l insulin and 10 nmol/l T3 until day 7 for
harvest, and this medium was replaced daily. 3T3-L1 cells
were cultured to confluence (day 0) and 2 days later, were
differentiated as described for HIB-1B cells.
Methylated cytosine mapping Bisulphite conversion of
genomic DNA prepared from cells or tissues was carried out
essentially as described by Clark et al. [24]. The modified
DNA was purified using a desalting column (Promega
Wizard DNA Clean-Up system; Promega, Madison, WI,
USA) Methylation was quantified by pyrosequencing using
Pyro Q-CpG software (Biotage, Charlottesvile, VA, USA)
and performed by The Genome Centre, Barts Hospital,
London, UK. Primer sequences and descriptions are provid-
ed (see Electronic supplementary material [ESM] Table 1),
products destined to be pyrosequenced were amplified with
5′-biotin-labelled primers to allow purification before
sequencing.
Methylated promoter reporter luciferase assays Ucp1
promoter fragments inserted into pGL3 firefly luciferase
reporter vectors [9] were either methylated by incubation
with SssI methylase to methylate all CpG residues or mock-
methylated by the addition of nuclease-free water instead of
SSSI. Vectors were then purified using a QiaQuick kit
(Qiagen, Valencia, CA, USA). Vectors were then trans-
fected into 80% confluent HIB-1B and 3T3-L1 cells as
previously described [4] using 3 µl/μg DNA of FuGene6
(Roche, Burgess Hill, UK) or 2 µl/μg DNA of Lipofect-
amine 2000 (Invitrogen) respectively according to the
manufacturers’ instructions. Thirty-six hours later, cells
were treated with forskolin in serum-free conditions,
harvested after 12 h, and firefly and Renilla luciferase
activities were measured using the Promega Dual-Glo
Luciferase Assay System. The activity of firefly luciferase
was normalised to that of Renilla luciferase.
Chromatin immunoprecipitation assays Nuclei, prepared as
described by Thomas et al. [25] were cross-linked (1%
formaldehyde for 10 min), lysed, sonicated and immuno-
precipitated with antibodies against TriMethH3K4 (Abcam,
Cambridge, UK) and DiMethH3K9 (Abcam) as described
previously [5]. Bound and input fractions were analysed by
quantitative real-time PCR (qRTPCR) using the primers
given in ESM Table 1. For the suppressed mark
(DiMethH3K9) a region of the alpha-fetoprotein (Afp) start
site (−82 to +94 bp) was chosen as a positive control
because this gene has been shown to be silenced in adult
mouse tissues [26]. The positive control for the expressed
mark (TriMethH3K4) was the start site of the proline-rich
Gla protein (PRGP2), which is a transmembrane protein
broadly produced in vertebrates across tissues [27]. The
amount of Ucp1 DNA was normalised to the amount of
Prgp2 (also known as Prrg2)o rAfp start site DNA in the
bound and input fractions, quantified by qRTPCR.
Real-time PCR Total RNAwas extracted from cultured cells
and tissue by use of TRI reagent (Sigma, Poole, UK). Before
RTPCR, samples were treated with DNA-free DNase to
remove contaminating genomic or plasmid DNA. Comple-
mentary DNA was generated using the cDNA synthesis kit
from Qiagen. Quantitative RTPCR was performed using Sybr
green(Qiagen)accordingtothemanufacturer’sin st ru ct io nsin
Rotor Gene 3000 (Corbett Research, Cambridge, UK). The
sequences of the primers used for qRTPCR are given in ESM
Table 1. Expression levels for all genes were normalised to
the internal control; 18S rRNA.
Oligonucleotide binding assay Nuclear extracts for electro-
phoretic mobility shift assays (EMSA) were prepared in the
presence of protease and protein phosphatase inhibitors as
described by Karmanlidis et al. [4]. The oligonucleotide
spanned the Ucp1-CRE3 regulatory element: CRE3 5′
CTCCTCTACAGCGTCACAGAGGGTC3′ and CRE2 5′
CACTGAACTAGTCGTCACCTTTCCA3′ (CRE motif is
in italics). Specific binding was established by coincubating
with 10-, 25- and 50-fold excess of unlabelled oligonucle-
otide. The effect of methylation of the CRE motif in CRE3
and CRE2 was established by coincubating with unlabelled
methylated CRE3 5′TCTCCTCTACAGC
MEGTCACA
GAGGGTC, or methylated CRE2 5′CACTGAACTAGT
C
MEGTCACCTTTCCA (C
MEG shows the position of the
methylated CpG). Competing unlabelled oligonucleotides
were added 15 min before the addition of labelled probe.
1166 Diabetologia (2010) 53:1164–1173Statistical analysis All the data were analysed with either
Student’s t test or two-way analysis of variance.
Results
CpG dinucleotide occurrence in the Ucp1 enhancer To
identify potential regulatory CpG dinucleotides in the
enhancer region of the Ucp1 promoter across species a
BLAST analysis (NCBI, Bethesda, MD, USA) against the
human and rat genomes was performed using a 621 bp
fragment surrounding a 221 bp region of the mouse
enhancer that had previously been shown to regulate gene
expression in mice (Fig. 1). The first objective was to
identify whether this region was homologous across species
and the second was to identify CpG dinucleotides of
interest and determine if they were also conserved across
species. This analysis identified a 94 bp fragment
(−2510 bp to −2416 bp) of the mouse enhancer that had
86% homology with the region −3805 bp to −3711 bp
upstream of human Ucp1. BLAST analysis also showed
two regions of homology with the rat genome. The first was
a 196 bp fragment of the mouse enhancer region (−2653 bp
to −2457 bp with 83% homology) and the second a 105 bp
fragment of the mouse enhancer region which shared 88%
homology with another region upstream of the rat Ucp1
gene (−400 bp to −2295 bp). Figure 1 shows these BLAST
analyses combined with the previous alignment published
by Rim and Kozak [9]. The conservation of this enhancer
during eutherian evolution has recently been reported [28],
in particular, the eutherian conservation of the two CREs in
the enhancer (designated CRE3 and CRE2 by Rim and
Kozak) as well as the thyroxine response element and
PPARE sequences were noted (Fig. 1).
Within the enhancer regions several CpG dinucleotides
were identified by observation (Fig. 1) but not a sufficient
number to be classed as a CpG island in any of the species,
as confirmed using an EMBOSS CpGPlot [29]. Interest-
ingly, the only CpG conserved through the three species
was present in the highly conserved CRE3. The human
BLAST did not reveal further CpG dinucleotides, although
the rat contains a similar quantity of CpGs to the mouse.
Six CpG dinucleotides (numbered 1 to 6) in a 460 bp
region of the mouse enhancer (−2500 to −2726 from the
transcription start site) were selected for studying methyl-
ation state using bisulphite mapping. CpG 1 and 2 flanked
the 5′ end of the Ucp1enhancer and CpG 5 and 6 flanked
the 3′ side. CpG 3 and 4 lay within the Ucp1 enhancer and
were part of CRE3 and CRE2 as shown in Fig. 1.B y
including CpGs beyond the recognised mouse Ucp1
enhancer it may be possible to determine if the observed
changes are on discrete CpGs, as has been identified for
genes of GLUT4 and leptin [13, 16], or are occurring over a
wider area of DNA.
CpG methylation state in the Ucp1 enhancer in adipocyte
cell lines We next employed bisulphite mapping to exam-
ine the CpG methylation state of the Ucp1 enhancer in
brown HIB-1B and white 3T3-L1 adipocytes. Ucp1
expression was increased ∼200-fold (p<0.001) by treating
differentiated HIB-1B cells with forskolin, but the same
treatment of 3T3-L1 cells elicited a very much smaller
b
a
Fig. 1 Location of CpGs and transcription factor binding sites on the
Ucp1 enhancer. a Selected CpGs of interest indicated by black flags
and numbered 1 to 6 relative to cyclic AMP response element (CRE)
sites, CRE2 and CRE4. A selection of transcription factors whose
binding has been previously described, are shown in their relative
positions. CREB, PPAR, PGC-1α, retinoic acid (RA), retinoid X
receptor (RXR), thyroid hormone receptor (TR), brown fat response
element (BRE) and nuclear factor erythroid derived 212 (NFE-212).
b Alignment of mouse, rat and human 350 bp of the Ucp1 enhancer.
These sequences identified by BLAST are aligned here using Vector
NTI. Highlighted grey regions are the core sequences (CGTCA) of the
CREs in the mouse promoter with CRE3 positioned upstream of
CRE2. CpGs chosen for analysis are underlined and in bold, these are
coded 1–6( 5 ′ to 3′) in superscript
Diabetologia (2010) 53:1164–1173 1167increase in Ucp1mRNA levels (Fig. 2a). The methylation
state of the six CpG dinucleotides in the Ucp1 enhancer did
not differ between undifferentiated and differentiated HIB-
1B or 3T3-L1 cells and there was no effect of forskolin on
the methylation of these CpGs in either cell type (results
not shown). The pattern of methylation differed between
CpG dinucleotide position across the Ucp1 enhancer of
HIB-1B cells, with the methylation state at CpG positions 3
and 4 lower (p<0.05) than at the other CpG dinucleotides
(Fig. 2b). Surprisingly, 3T3-L1 cells had significantly lower
methylation levels than HIB-1B cells at CpG 1, CpG 4 and
CpG 6 (p<0.05) (Fig. 2b). In contrast, CpG 3 was more
methylated in 3T3-L1 cells than in HIB-1B cells (p<0.001)
but there was no significant difference in methylation at
CpG 5.
To assess the functional importance of methylation state
on Ucp1 expression we next examined the effects of 5-
aza-deoxycytidine (a methyl transferase inhibitor) which
demethylates CpG dinucleotides on Ucp1 methylation and
gene expression. Preincubation of 3T3-L1 cells with
5-aza-deoxycytidine significantly reduced DNA methyla-
tion by 20–50% at all CpG dinucleotides except at position
4 in the Ucp1 enhancer (Fig. 3a) and increased both control
and forskolin-stimulated Ucp1 expression. In HIB-1B cells
preincubation with 5-aza-deoxycytidine increased basal
Ucp1 expression (Fig. 3b) and inhibited forskolin-
dependent induction of Ucp1 expression.
We next examined the effect on transcriptional activity
of methylating CpG dinucleotides in the Ucp1 promoter by
treating with the DNA methyltransferase, SssI, a series of
different promoter fragments inserted into pGL3 luciferase
reporter plasmids, and then transfected into HIB-1B or 3T3-
L1 cells. Successful methylation of the vectors was
confirmed by subsequent digestion with a methylation
sensitive restriction enzyme (HpaII) and controls were
mock-methylated in the absence of SssI. Figure 4a,b shows
the four Ucp1 promoter constructs that were examined:
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Fig. 2 Ucp1 mRNA expression and CpG dinucleotide methylation of
the Ucp1 enhancer in differentiated HIB-1B and 3T3-L1 cells. a Effect
of vehicle (white bar) and 10 µmol/l forskolin (black bar) on Ucp1
mRNA abundance normalised to 18S rRNA. b DNA was extracted
from differentiated HIB-1B (white bars) and 3T3-L1 cells (black bars),
bisulphite modified, amplified by PCR and pyrosequenced to
determine CpG methylation over positions 1–6 of the Ucp1 enhancer.
Bars represent mean ± SEM (n=3 experiments). Significantly different
from control, **p<0.01; significant difference between adipose tissues
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Fig. 3 Effect of 5-aza-deoxycytidine on CpG dinucleotide methyla-
tion of the Ucp1 enhancer and Ucp1 mRNA expression in HIB-1B
and 3T3-L1 cells. a CpG methylation over positions 1 to 6 of the
Ucp1 enhancer in 3T3-L1 cells grown to 80% confluence and treated
with vehicle alone (white bars) or 1 μmol/l 5-aza-deoxycytidine (black
bar) for 48 h. b Ucp1 mRNA transcription normalised to 18S rRNA in
3T3-L1 cells and HIB-1B cells treated with 1 μmol/l 5-aza-
deoxycytidine or vehicle alone for 48 h before treatment with
10 µmol/l forskolin (black bars) or vehicle (white bars). The data are
presented as fold increase in Ucp1 mRNA over vehicle only 3T3-L1
cells. Bars represent mean ± SEM (n=3 experiments)
1168 Diabetologia (2010) 53:1164–1173construct 1 is the empty vector; construct 2 contains the
proximal promoter and CRE 4; construct 3 contains both
the proximal promoter and the enhancer (which contains
CRE 1, 2 and 3); construct 4 contains the entire 3.1 kb
Ucp1 promoter. When transfected into HIB-1B cells,
transcription from construct 3 (enhancer plus proximal
promoter) showed the highest transcriptional activity with
lower activities in constructs 2 (proximal promoter) and 4
(3.1 kb Ucp1 promoter), compared with the control mock-
methylated empty vector (construct 1). Addition of for-
skolin stimulated (p<0.01) the transcriptional activity of all
Ucp1 mock-methylated promoter constructs. SssI methyla-
tion downregulated (p<0.001) the transcriptional activity of
all constructs to basal values. When the constructs were
transfected into 3T3-L1 cells (Fig. 4b), the transcriptional
activity was reduced (p<0.001) by more than half of that
observed in HIB-1B cells and methylation of the luciferase
vector again decreased activity to basal levels.
Effect of cold stress on CpG methylation state in the Ucp1
enhancer in vivo The studies in adipocyte cell lines clearly
demonstrated a role for CpG methylation in the control of
Ucp1 transcription so we next determined whether there
were any in vivo differences in the methylation state of the
six CpG dinucleotides in the Ucp1enhancer region between
brown and white adipose tissues in mice exposed to a cold
environment. Bisulphite mapping of the Ucp1 enhancer
region was performed on DNA isolated from four tissues
(intrascapular BAT [iBAT]; intrascapular WAT [iWAT];
gonadal WAT [gWAT] and liver) and then analysed by
bisulphite mapping and pyrosequencing. The iBAT and
iWAT were separated by dissection. Ucp1 expression was
significantly (p<0.001) higher in iBAT compared with
iWAT, and very low but clearly present in gWAT. Cold
adaptation significantly (p<0.001) increased Ucp1 mRNA
four- to sixfold in all adipose tissues sampled and no
expression was observed in the liver, which acted as a
control non-Ucp1-expressing tissue (Fig. 5a).
There was no effect of cold adaptation on the percentage
of CpG dinucleotide methylation in any of the adipose
tissues measured but methylation differed considerably
between tissue and CpG position (Fig 5b,c). At CpG
dinucleotide positions 1–4, iBAT exhibited the lowest
methylation state, liver was consistently the highest, and
iWAT and gWAT were intermediate (p<0.01). Methylation
at CpG dinucleotide position 5 and 6, in warm-acclimatised
mice, was similar in all tissues (Fig. 5c) but in cold-
acclimatised mice, methylation in liver significantly (p<
0.01) increased to 92%, although there was no change in
the adipose tissues. The two white adipose tissue depots
(gWAT and iWAT) showed very similar methylation
patterns at all positions despite the higher levels of Ucp1
expression in iWAT. In the adipose tissues, methylation was
significantly lower in CpG dinucleotide positions 3 and 4,
compared with 1, 2, 5 and 6 (p<0.05).
Since CpG at positions 3 and 4 were within CRE3 and
CRE2, respectively, we next established whether meth-
ylation of these CpGs in a short double-stranded
oligonucleotide with sequences flanking either CRE3 or
CRE2, influenced binding of nuclear protein by EMSA.
Methylation of the CpG in CRE2 markedly decreased the
competition of excess oligonucleotide with nuclear
proteins prepared from brown adipocytes (HIB-1B), to
bind to the labelled CRE2 unmethylated oligonucleotide
(Fig. 6). In contrast, methylation of the CpG in the CRE3
oligonucleotide had no effect on competition with nuclear
proteins, suggesting that the methylation of the CpG at
position 4, within the CRE2 sequence, may be of
functional significance.
We next employed chromatin immunoprecipitation
(ChIP) assays to establish whether the Ucp1 promoter
region was associated with histone marks, indicating either
active (TriMethH3K4) or repressed (DiMethH3K9) chro-
matin states. The start of Ucp1 transcription was examined
because the TriMethH3K4 modification is found around the
start of transcription of actively transcribed genes and
diminishes moving upstream and downstream from this
Ucp1
Mock Mock
Meth Meth
Mock Mock
Meth
Mock
Meth Meth
Mock Mock
h Meth
Ucp1
Mock Mock
Meth
Mock Mock
Meth Meth
Mock
Meth et
Mock Mock
h Meth
0 50 100 150 200 0 50 100 150 200
Fold induction
0 50 100 150 200 0 50 100 150 200
Fold induction
a
b
Fig. 4 Effect of methylation of pGL3 luciferase reporter constructs
containing various fragments of the Ucp1 promoter and transfected
into HIB1B and 3T3-L1 cells. a Fold expression of SSSI methylated
(Meth) and mock-methylated (Mock) reporter constructs in HIB-1B
cells treated with vehicle (white bars) and 10 μmol/l forskolin (black
bars). Black circles represent CREs 1, 3, 2 and 4, in order left to right,
and the dashed line indicates missing promoter sequences between
enhancer and proximal promoter. b Fold expression of SssI methyl-
ated (Meth) and mock-methylated (Mock) reporter constructs in 3T3-
L1 cells treated with vehicle (white bars) and 10 mol/l forskolin (black
bars). Bars represent mean ± SEM (n=3 experiments)
Diabetologia (2010) 53:1164–1173 1169point [30]. In both iBAT and gWAT of warm-acclimatised
mice, enrichment of the Ucp1 promoter with this mark was
low relative to the control gene, Prgp2 (Fig. 7a). In the
cold-adapted group the Ucp1 promoter remained depleted
in TriMethH3K4 immunoprecipitates in gWAT but showed
great enrichment (p<0.01) in iBAT, suggesting that the
promoter became associated with active chromatin. This
result corresponded to the large increase in Ucp1 mRNA
expression in iBAT in cold-acclimatised mice. When the
chromatin was immunoprecipitated with an antibody
against the repressed DiMethH3K9 mark (Fig. 7b), the
Ucp1 promoter was depleted of this mark in nuclei from
both types of adipose tissue relative to the repressed control
gene, Afp start site. Association of the repressed
DiMethH3K9 mark with the Ucp1 enhancer region relative
to Afp (Fig. 7c) demonstrated that gWAT was enriched
compared with iBAT, although this was only significantly
different (p<0.05) in the cold-adapted mice. Taken together
the ChIP assay results suggest that the Ucp1 promoter is
associated with an active and repressed chromatin state in
iBAT and gWAT, respectively, and that cold induces a more
active chromatin state around the Ucp1 promoter start site,
in line with a rise in Ucp1 expression.
Discussion
In this study we demonstrate that the methylation state of
CpG dinucleotides in the Ucp1 enhancer exhibits position-
specific and adipose tissue-specific patterns in both cell
lines and murine adipose tissue and that promoter methyl-
ation has functional importance in the regulation of Ucp1
expression.
CpG dinucleotide methylation state in the Ucp1 enhanc-
er was not altered during either differentiation of white
3T3-L1 and brown HIB-1B pre-adipocytes or treatment
with forskolin, despite increased Ucp1 expression, Surpris-
ingly, methylation state was higher at CpG dinucleotide
positions 1, 4 and 6 in HIB-1B compared with 3T3-L1
cells, and only clearly lower in HIB-1B cells at position 3.
Similar analysis of tissue samples taken in vivo demon-
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Fig. 5 Effect of cold stress on expression of Ucp1 mRNA and
methylation of CpG dinucleotides in the Ucp1 enhancer in different
tissues from mice. a Ucp1 mRNA abundance normalised to 18S
rRNA in iBAT, iWAT, gWAT and liver from mice housed in either
warm (22±2°C, white bars) or cold (8±2°C, black bars) conditions for
24 h before sampling. b Methylation of CpG dinucleotides in
positions 1 to 6 of the Ucp1 enhancer in tissues from mice housed
in a warm environment. c Methylation of CpG dinucleotides in
positions 1 to 6 of the Ucp1 enhancer in tissues from mice housed in a
cold environment: iBAT (black bars), iWAT (white bars), gWAT (bars
with horizontal stripes) and liver (bars with vertical stripes). Bars
represent mean ± SEM (n=4 mice). Significant difference between
warm and cold, **p<0.01
1170 Diabetologia (2010) 53:1164–1173strated that methylation state was consistently lower in BAT
compared with WAT and liver, at CpG dinucleotide
positions 1–4 in the Ucp1 enhancer. Furthermore, the
methylation state of CpG dinucleotides at positions 3 and
4, in the CRE3 and CRE2 sequences, respectively, were the
lowest in all tissues, with position 4 within CRE2 being less
than 10%. Binding of a labelled oligonucleotide probe
containing CRE2 and flanking sequences, to brown
adipocyte nuclear proteins, was displaced in a
concentration-dependent manner by excess unlabelled
probe but not when the excess unlabelled probe was
methylated at CpG dinucleotide position 4. A similar study
examining a labelled CRE3 oligonucleotide probe failed to
observe any decrease in competition with excess unlabelled
methylated probe. We have previously demonstrated using
EMSA and ChIP that HIB-1B nuclear extracts contain bZip
transcription factors, including CREB, which bind to CREs
[4, 5], therefore suggesting that methylation of the CpG
dinucleotide in the CRE2 sequence, decreases binding of
transcription factors.
Further functional evidence that Ucp1 promoter methyl-
ation is linked to gene expression was obtained by
treatment with 5-aza-deoxycytidine in 3T3-L1 cells. 5-
Aza-deoxycytidine treatment decreased methylation of the
Ucp1 enhancer in 3T3-L1 cells and significantly increased
expression of basal and forskolin-stimulated Ucp1 expres-
sion. Furthermore, methylation of luciferase reporter plas-
mids containing the whole 3.1 kb, or fragments of the Ucp1
promoter, before transfection into HIB-1B or 3T3-L1 cells,
inhibited transcriptional activity from the promoter. This
effect was greatest for reporter vectors containing just the
enhancer and promoter sequences where the CREs are
located, providing strong evidence that methylation of CpG
dinucleotides in CREs in the Ucp1 promoter, inhibits
transcription. Similar evidence for the role of methylation
in the control of other genes has been reported [13, 31–36].
Global demethylation of the HIB-1B cells with 5-aza-
deoxycytidine unexpectedly inhibited forskolin-induced
Ucp1 expression, suggesting a role for methylation state
of unidentified factors that inhibit brown adipogenesis.
Treatment of mouse Swiss 3T3 fibroblasts with 5-aza-
deoxycytidine has previously been shown to direct this cell
line to the myogenic lineage [37]. Lineage tracing studies
have recently discovered that BAT shares a common cell
progenitor with muscle and not WAT depot cells, as
previously thought [38]. Downregulation of the BAT-
specific gene Ucp1 in HIB-1B cells, but not in 3T3-L1
cells, by 5-aza-deoxycytidine may therefore be the result of
commitment to a myogenic lineage in the brown adipocyte
cell line.
Previous studies have demonstrated that methylation of
CpG dinucleotides in CREs inhibits the binding of CREB
and transcriptional responses to cAMP [19, 36]. CRE3 and
CRE2 have previously been shown to bind CREB and are
essential for the maximal response of the gene to adrenergic
stimulation [9]. However, the lower CpG methylation states
in these CREs were not altered by either short-term (24 h)
exposure to cold in vivo or treatment of adipocyte cell lines
with forskolin, suggesting that methylation state does not
play a role in acute adrenergic-stimulated Ucp1 expression.
These two CpGs may be held in a lower state of
methylation to allow response to stimuli because they are
also 3–15 bases from the PPARE, brown fat regulatory
element and NF-E2 response element, all of which have
been implicated in the control of brown adipose tissue
differentiation [9, 10]. Interestingly, the CpG dinucleotide
in position 3 was the only example of methylation state
being lower in HIB-1B, the Ucp1-expressing cell line,
compared with 3T3-L1 cells.
The ChIP studies demonstrated that the amount of the
active TriMethH3K4 mark bound to the proximal Ucp1
promoter increased in iBAT but not in gWAT following
cold exposure. Conversely, the Ucp1 promoter in gWAT
was more enriched with the repressed DiMethH3K4 histone
mark, compared with in iBAT. These results agree with
those of Kiskinis et al. [20] suggesting that the control of
Ucp1 expression involves modification of histone tails
associated with the Ucp1 locus. Enrichment of the enhancer
with the repressed histone mark was greater in gWAT than
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Fig. 7 Chromatin immunoprecipitation analysis of the association of
the Ucp1 promoter with active (TriMethH3K4) and repressed
(DiMethH3K9) histone marks. a Immunoprecipitation by Tri-
MethH3K4 of the Ucp1 promoter close to the transcription start site,
relative to the promoter of the expressed reference gene Prgp2.
b Immunoprecipitation by DiMethH3K9 of the Ucp1 promoter close
to the transcription start site, relative to the promoter of the suppressed
gene Afp. c Immunoprecipitation by DiMethH3K9 of the Ucp1
enhancer region, relative to the promoter of the suppressed reference
gene Afp. Adipose tissue nuclei were extracted and cross-linked and
the DNA was immunoprecipitated using anti-TriMethH3K4 or anti-
DiMethH3K9. Ucp1 start site and Prgp2, Afp start site DNA in the
bound and input fractions were quantified by qRTPCR. iBAT and
gWAT were taken from mice housed in either warm (22±2°C, white
bars) or cold, (8±2°C, black bars) conditions for 24 h before
sampling. Bars represent the mean ± SEM of triplicate assays
Diabetologia (2010) 53:1164–1173 1171the proximal promoter region, suggesting that histone
modification may differ across the 3.1 kb Ucp1 5′
regulatory region.
In conclusion, we demonstrate that CpG methylation of
the Ucp1 enhancer exhibits CpG-position and tissue-
specific patterns and, using cell lines, that this difference
may have functional importance suggesting that the
regulation of Ucp1 expression involves chromatin modifi-
cation. The results identify chromatin remodelling as a
plausible target for future research to identify mechanisms
to upregulate Ucp1 expression in adipocytes in the search
for novel treatments of obesity.
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